Group items tagged

TYRX is a mesh envelope designed to hold an implantable cardiac device or implantable neurostimulator. It stabilises the device after implantation, as well as releases antimicrobial agents, minocycline and rifampin over a minimum of seven days. The envelope is fully absorbed around nine weeks after implantation.

PowerVision focuses on creating fluid-based intraocular lens implants. Under the agreement, Alcon will make payments for specified regulatory and commercial milestones that are achieved from 2023.

The Translational Genomics Research Institute (TGen) in the US has signed a licensing agreement with integrated diagnostics firm Advanced Biological Laboratories (ABL) to market its tuberculosis (TB) test technology.

The US Food and Drug Administration (FDA) has sent warning letters to a Johnson & Johnson unit, Mentor Worldwide, and Sientra for failure to comply with its post-approval study requirements for breast implants.

Researchers at Purdue University have created a sensor that could track glutamate, which is associated with neurological conditions such as migraines, Alzheimer's and Parkinson's.

The US Food and Drug Administration (FDA) has proposed a new policy intended to modernise and improve the quality of mammography, which is used for breast cancer screening and diagnosis.

Clinical diagnostic solutions maker Bio-Rad Laboratories has reported data from three clinical studies using its Droplet Digital PCR (ddPCR) powered liquid biopsy to track cancer progression and assess therapy response.

Scientists at Lawson Health Research Institute in Canada have developed a new computational model that could assess epigenetic patterns to allow detection of rare hereditary diseases.

AngioDynamics has received approval from the US Food and Drug Administration (FDA) for an investigational device exemption (IDE) application of its NanoKnife System in the treatment of stage III pancreatic cancer.

Smith & Nephew has entered an agreement to acquire medical device company Leaf Healthcare, including its patient mobility monitoring device Leaf Patient Monitoring System.

Business consultancy Frost & Sullivan has made a series of predictions for the future of the patient monitoring device market, following its recently published analysis of investments and trends in the industry.

Synchron has launched the first clinical trial of its neural interface technology Stentrode.

Researchers at Stanford University School of Medicine have developed a new artificial intelligence (AI) algorithm that can identify whether or not a patient is at risk of developing familial hypercholesterolemia (FH), a cholesterol-raising genetic disease, with up to 88% accuracy.

London-based medtech startup Medbelle has raised $7m in series A funding towards establishing the world's first 'digital hospital'.

Scientists have developed a new technique to measure brain function in milliseconds using magnetic resonance imaging (MRI).

The Australian Therapeutic Goods Administration (TGA) has announced plans to overhaul the regulatory system for medical devices in the country to increase patient safety.

A research team at the University of Sheffield has secured funding to develop a monitoring system to assess a patient's health and wellbeing based on their gait.

Medtronic has reported positive data from a retrospective analysis of the ENDURANCE and ENDURANCE Supplemental clinical trials.

The US Food and Drug Administration (FDA) has granted clearance to Innoblative Designs' electrosurgical device SIRA RFA.

A six-month trial at Queen Mary's Hospital in Sidcup, UK has demonstrated the successful implementation of eTriage, an electronic triage system designed to reduce hospital waiting times by accelerating initial personal assessment.